About

Board of Directors

The board of Ascelia Pharma consists of:

Peter Benson

Peter Benson

Born 1955. Chairman of the board of directors since 2017.

Professional background
Peter Benson is co-founder and Managing Partner of Sunstone Capital Life Science Ventures and chairman of Alligator Bioscience AB, which is listed on Nasdaq Stockholm. Peter Benson has extensive experience from the Life Science sector as an investor and in management positions. Peter Benson has previously inter alia been Head of Life Science Ventures at Vækstfonden (the Danish Growth Fund) and a part of Pharmacia AB’s group management.

Education
Graduate in business administration from Lund University, Sweden. MA in Economics from the University of California, US.


Bo Jesper Hansen

Bo Jesper Hansen

Born 1958. Member of the board of directors since 2010.

Professional background
Bo Jesper Hansen has extensive experience from orphan drug research and development, international marketing and business development. Bo Jesper Hansen is and has previously been chairman and member of the board of directors in a number of biotech and pharma companies, including executive chairman of Swedish Orphan Biovitrum AB (publ) and Karolinska Development AB.

Education
M.D. and Ph.D. from University of Copenhagen, Denmark.


Hans Maier

Hans Maier

Born 1955. Member of the board of directors since 2017.

Professional background
Hans Maier has held several senior positions within Schering AG and Bayer AG, inter alia as Head of Corporate Strategy and Business Development of Schering AG and President of the Global Business Unit Diagnostic Imaging in both Schering AG and Bayer AG. Hans Maier is member of several advisory boards, inter alia the Fraunhofer Institute for Medical Image Computing and the German Heart Center Berlin.

Education
Ph.D. in Economics and Social Sciences and Degree in Political Science from Freie Universität Berlin, Germany.

Niels Mengel

Niels Mengel

Born 1948. Member of the board of directors since 2000.

Professional background
Niels Mengel is Founding Partner, chairman and CEO of Øresund-Healthcare Capital. Niels Mengel has extensive experience from the healthcare industry as an investor. Niels Mengel has previously inter alia been Executive Vice President at ISS World Services A/S and Director at PA Consulting Group.

Education
M.B.A. from London Business School, England. M.Sc. in Macro Economy and Finance from University of Copenhagen, Denmark.

René Spogárd

René Spogárd

Born 1954. Member of the board of directors since 2017.

Professional background
René Spogárd is chairman and investor in a number of companies including JEKA Fish A/S, Bollerup Jensen A/S and Flex Funding A/S. René Spogárd has extensive experience from investing in the healthcare sector and board positions in a public environment. René Spogárd has previously inter alia been owner and Managing Director at TNS Gallup A/S and Director at TNS plc (listed on London Stock Exchange).

Education
H.D. in Marketing from Copenhagen Business School, Denmark.

Helena Wennerström

Helena Wennerström

Born 1965. Member of the board of directors since 2017.

Professional background
Helena Wennerström has been Executive Vice President of Bulten AB (publ) since 2014 and has been its Chief Financial Officer since 2006. Helena Wennerström is also responsible for the Investor Relations and Communications activities and IT within Bulten AB. Helena Wennerström has earlier served finance roles at Digitalfabriken and Topcon.

Education
Master of Science in Business Administration and Economics from Örebro University.